BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 35874167)

  • 1.
    El-Gazzar A; Kang H; Fratzl-Zelman N; Webb E; Barnes AM; Jovanovic M; Mehta SG; Datta V; Saraff V; Dale RK; Rauch F; Marini JC; Högler W
    Bone Rep; 2022 Dec; 17():101603. PubMed ID: 35874167
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Somatic SMAD3-activating mutations cause melorheostosis by up-regulating the TGF-β/SMAD pathway.
    Kang H; Jha S; Ivovic A; Fratzl-Zelman N; Deng Z; Mitra A; Cabral WA; Hanson EP; Lange E; Cowen EW; Katz J; Roschger P; Klaushofer K; Dale RK; Siegel RM; Bhattacharyya T; Marini JC
    J Exp Med; 2020 May; 217(5):. PubMed ID: 32232430
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dysregulated TGF-β signaling alters bone microstructure in a mouse model of Loeys-Dietz syndrome.
    Dewan AK; Tomlinson RE; Mitchell S; Goh BC; Yung RM; Kumar S; Tan EW; Faugere MC; Dietz HC; Clemens TL; Sponseller PD
    J Orthop Res; 2015 Oct; 33(10):1447-54. PubMed ID: 26173585
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel pathogenic variant located just upstream of the C-terminal Ser423-X-Ser425 phosphorylation motif in SMAD3 causing Loeys-Dietz syndrome.
    Ishii S; Fujiwara T; Yagi H; Takeda N; Ando M; Yamauchi H; Inuzuka R; Taniguchi Y; Hatano M; Komuro I
    Mol Genet Genomic Med; 2023 Dec; 11(12):e2257. PubMed ID: 37864304
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Further delineation of Loeys-Dietz syndrome type 4 in a family with mild vascular involvement and a TGFB2 splicing mutation.
    Ritelli M; Chiarelli N; Dordoni C; Quinzani S; Venturini M; Maroldi R; Calzavara-Pinton P; Colombi M
    BMC Med Genet; 2014 Aug; 15():91. PubMed ID: 25163805
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The transforming growth factor-beta/SMAD signaling pathway is present and functional in human mesangial cells.
    Poncelet AC; de Caestecker MP; Schnaper HW
    Kidney Int; 1999 Oct; 56(4):1354-65. PubMed ID: 10504488
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The first reported case of Loeys-Dietz syndrome in a patient with biallelic SMAD3 variants.
    Baskin SM; Morris SA; Vara A; Hecht JT; Farach LS
    Am J Med Genet A; 2020 Nov; 182(11):2755-2760. PubMed ID: 32935439
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transforming growth factor-beta repression of matrix metalloproteinase-1 in dermal fibroblasts involves Smad3.
    Yuan W; Varga J
    J Biol Chem; 2001 Oct; 276(42):38502-10. PubMed ID: 11502752
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genomic Observations of a Rare/Pathogenic
    Richter JE; Samreen A; Vadlamudi C; Helmi H; Mohammad AN; Wierenga K; Hines S; Atwal PS; Caulfield TR
    Medicina (Kaunas); 2019 May; 55(5):. PubMed ID: 31096651
    [No Abstract]   [Full Text] [Related]  

  • 10. Regulation of RANKL-induced osteoclastogenesis by TGF-β through molecular interaction between Smad3 and Traf6.
    Yasui T; Kadono Y; Nakamura M; Oshima Y; Matsumoto T; Masuda H; Hirose J; Omata Y; Yasuda H; Imamura T; Nakamura K; Tanaka S
    J Bone Miner Res; 2011 Jul; 26(7):1447-56. PubMed ID: 21305609
    [TBL] [Abstract][Full Text] [Related]  

  • 11. YAP/TAZ regulates TGF-β/Smad3 signaling by induction of Smad7 via AP-1 in human skin dermal fibroblasts.
    Qin Z; Xia W; Fisher GJ; Voorhees JJ; Quan T
    Cell Commun Signal; 2018 Apr; 16(1):18. PubMed ID: 29695252
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activations of ERK1/2 and JNK by transforming growth factor beta negatively regulate Smad3-induced alkaline phosphatase activity and mineralization in mouse osteoblastic cells.
    Sowa H; Kaji H; Yamaguchi T; Sugimoto T; Chihara K
    J Biol Chem; 2002 Sep; 277(39):36024-31. PubMed ID: 12130649
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of TGF-beta/Smad signaling pathway on lung myofibroblast differentiation.
    Gu L; Zhu YJ; Yang X; Guo ZJ; Xu WB; Tian XL
    Acta Pharmacol Sin; 2007 Mar; 28(3):382-91. PubMed ID: 17303001
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TGF-beta activated Smad signalling leads to a Smad3-mediated down-regulation of DSPP in an odontoblast cell line.
    He WX; Niu ZY; Zhao SL; Jin WL; Gao J; Smith AJ
    Arch Oral Biol; 2004 Nov; 49(11):911-8. PubMed ID: 15353247
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transforming growth factor-β(1) represses bone morphogenetic protein-mediated Smad signaling in pulmonary artery smooth muscle cells via Smad3.
    Upton PD; Davies RJ; Tajsic T; Morrell NW
    Am J Respir Cell Mol Biol; 2013 Dec; 49(6):1135-45. PubMed ID: 23937428
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Smad3 mediates transforming growth factor-beta-induced alpha-smooth muscle actin expression.
    Hu B; Wu Z; Phan SH
    Am J Respir Cell Mol Biol; 2003 Sep; 29(3 Pt 1):397-404. PubMed ID: 12702545
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potentiation of Smad transactivation by Jun proteins during a combined treatment with epidermal growth factor and transforming growth factor-beta in rat hepatocytes. role of phosphatidylinositol 3-kinase-induced AP-1 activation.
    Peron P; Rahmani M; Zagar Y; Durand-Schneider AM; Lardeux B; Bernuau D
    J Biol Chem; 2001 Mar; 276(13):10524-31. PubMed ID: 11134003
    [TBL] [Abstract][Full Text] [Related]  

  • 18. KLF17 empowers TGF-β/Smad signaling by targeting Smad3-dependent pathway to suppress tumor growth and metastasis during cancer progression.
    Ali A; Zhang P; Liangfang Y; Wenshe S; Wang H; Lin X; Dai Y; Feng XH; Moses R; Wang D; Li X; Xiao J
    Cell Death Dis; 2015 Mar; 6(3):e1681. PubMed ID: 25766320
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional analysis of cell lines derived from SMAD3-related Loeys-Dietz syndrome patients provides insights into genotype-phenotype relation.
    de Wagenaar NP; van den Bersselaar LM; Odijk HJHM; Stefens SJM; Reinhardt DP; Roos-Hesselink JW; Kanaar R; Verhagen JMA; Brüggenwirth HT; van de Laar IMBH; van der Pluijm I; Essers J
    Hum Mol Genet; 2024 Mar; ():. PubMed ID: 38538566
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic mucocutaneous candidiasis and connective tissue disorder in humans with impaired JNK1-dependent responses to IL-17A/F and TGF-β.
    Li J; Ritelli M; Ma CS; Rao G; Habib T; Corvilain E; Bougarn S; Cypowyj S; Grodecká L; Lévy R; Béziat V; Shang L; Payne K; Avery DT; Migaud M; Boucherit S; Boughorbel S; Guennoun A; Chrabieh M; Rapaport F; Bigio B; Itan Y; Boisson B; Cormier-Daire V; Syx D; Malfait F; Zoppi N; Abel L; Freiberger T; Dietz HC; Marr N; Tangye SG; Colombi M; Casanova JL; Puel A
    Sci Immunol; 2019 Nov; 4(41):. PubMed ID: 31784499
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.